InspireMD Files 8-K with Financials and Disclosures

Ticker: NSPR · Form: 8-K · Filed: Sep 16, 2024 · CIK: 1433607

Inspiremd, INC. 8-K Filing Summary
FieldDetail
CompanyInspiremd, INC. (NSPR)
Form Type8-K
Filed DateSep 16, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: 8-k, financials, disclosure

TL;DR

InspireMD dropped an 8-K with financials and disclosures on 9/16.

AI Summary

InspireMD, Inc. filed an 8-K on September 16, 2024, reporting on events including a Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, incorporated in Delaware, is based in Tel Aviv, Israel, and operates in the surgical and medical instruments sector.

Why It Matters

This filing provides investors with updated financial information and regulatory disclosures, offering insights into the company's current operational status and compliance.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically contains standard disclosures and financial updates without immediate, significant new risks.

Key Numbers

Key Players & Entities

FAQ

What specific events are detailed in the Regulation FD Disclosure and Other Events sections of this 8-K?

The provided text indicates the filing includes a Regulation FD Disclosure and Other Events, but does not specify the exact nature of these events.

When was InspireMD, Inc. previously known as Saguaro Resources, Inc. and when did the name change occur?

The filing states the former company name was Saguaro Resources, Inc. and the date of the name change was April 28, 2008.

What is InspireMD, Inc.'s primary business sector?

InspireMD, Inc. operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, with SIC code 3841.

What is the principal executive office address for InspireMD, Inc.?

The principal executive offices are located at 4 Menorat Hamaor St., Tel Aviv, Israel, 6744832.

What is the fiscal year end for InspireMD, Inc.?

The fiscal year end for InspireMD, Inc. is December 31.

Filing Stats: 569 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-09-16 07:32:32

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: September 16, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing